Recent studies have revealed that vascular cells can produce reactive oxygen species (ROS) through NAD(P)H oxidase, which may be involved in vascular injury. However, the pathological role of vascular NAD(P)H oxidase in diabetes or in the insulin-resistant state remains unknown. In this study, we examined the effect of high glucose level and free fatty acid (FFA) (palmitate) on ROS production in cultured aortic smooth muscle cells (SMCs) and endothelial cells (ECs) using electron spin resonance spectroscopy. Exposure of cultured SMCs or ECs to a high glucose level (400 mg/dl) for 72 h significantly increased the free radical production compared with low glucose level exposure (100 mg/dl). Treatment of the cells for 3 h with phorbol myristic acid (PMA), a protein kinase C (PKC) activator, also increased free radical production. This increase was restored to the control value by diphenylene iodonium, a NAD(P)H oxidase inhibitor, suggesting ROS production through PKC-dependent activation of NAD(P)H oxidase. The increase in free radical production by high glucose level exposure was completely restored by both diphenylene iodonium and GF109203X, a PKC-specific inhibitor. Exposure to palmitate (200 µmol/l) also increased free radical production, which was concomitant with increases in diacylglycerol level and PKC activity. Again, this increase was restored to the control value by both diphenylene iodonium and GF109203X. The present results suggest that both high glucose level and palmitate may stimulate ROS production through PKC-dependent activation of NAD(P)H oxidase in both vascular SMCs and ECs. This finding may be involved in the excessive acceleration of atherosclerosis in patients with diabetes and insulin resistance syndrome.
T
he production of reactive oxygen species (ROS) has been shown to be increased in patients with diabetes (1) (2) (3) (4) (5) (6) . The increased ROS production may be involved in the onset or development of diabetic vascular complications. It has been postulated that hyperglycemia, a key clinical manifestation of diabetes, may produce ROS through formation of advanced glycation end products (AGEs) (3, 4) and altered polyol pathway activity (5) . Recently, however, a growing body of experimental evidence has shown that vascular cells, such as smooth muscle cells and endothelial cells, can produce ROS through activation of NAD(P)H oxidase (7) (8) (9) (10) (11) (12) . Mohazzab et al. (7) and Rajagopalan et al. (9) have shown that this enzyme is the most important source of ROS in intact arteries rather than arachidonic acid-metabolizing enzymes, xanthine oxidase, or mitochondrial sources. This enzyme has also been implicated in the pathogenesis of angiotensin II-induced hypertension and vascular smooth muscle hypertrophy (8, 10, 12) and may also contribute to impaired endothelium-dependent vascular relaxation secondary to inactivation of nitric oxide by ROS (9) . However, to our knowledge, there is no report regarding the effect of diabetes or high glucose level on ROS production through NAD(P)H oxidase. In phagocytic cells, one of the regulators of NADPH oxidase activity may be protein kinase C (PKC) (13) (14) (15) . Numerous studies, including ours, have shown that high glucose levels or diabetes may activate PKC in various vascular cells (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . Therefore, high glucose or diabetes might stimulate ROS production through PKC-dependent activation of NAD(P)H oxidase in vascular cells. The present study was undertaken to examine the effect of high glucose level on ROS production through activation of NAD(P)H oxidase in cultured aortic smooth muscle cells and endothelial cells. In the present study, we measured the reduction rate of nitroxiradical probe (spin clearance rate), which represents the rate of free radical production in intact cells, using electron spin resonance (ESR) spectroscopy (28) (29) (30) 6) .
Both diabetes and the insulin-resistant state are linked with atherosclerosis. One of the metabolic features of insulin resistance is a defect in the insulin-mediated lowering action of fatty acids as well as a defect in glucose disposal. Several reports have shown that plasma free fatty acids (FFAs) may affect vascular functions. Raising plasma FFAs in minipigs with intralipid and heparin acutely elevates vascular resis-tance and raises blood pressure (31) . Raising FFAs systematically in healthy normotensive volunteers impairs the lower extremity vascular response to methacholine, an endotheliumdependent dilator (32) . The elevated FFAs in obese hypertensive subjects are extremely resistant to suppression by insulin and correlate with blood pressure (33, 34) . In addition, we showed that FFAs-especially palmitate, which is a major saturated FFA in plasma-could stimulate diacylglycerol (DAG) synthesis through de novo pathway in cultured endothelial cells and probably activate PKC (35) . From this evidence, we speculated that FFA as well as high glucose level might affect ROS production and subsequently alter various vascular functions. In the present study, therefore, we also examined the effect of palmitate on ROS production in cultured vascular cells.
RESEARCH DESIGN AND METHODS
Cell culture. Bovine aortic smooth muscle cells and endothelial cells were obtained from calf aorta as described (17, 18) . Both cell types were cultured with Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal calf serum, 100 mU/ml penicillin, and 100 mg/ml streptomycin at 37°C in an atmosphere of 95% O 2 /5% CO 2 . Every 5-10 days, the cells were subcultured by 0.25% trypsin (Gibco) harvesting. Synthesis of acetoxymethyl-2,2,6,6-tetramethylpiperidine-1-oxyl-3-carboxylate. We synthesized acetoxymethyl-2,2,6,6-tetramethylpiperidine-1-oxyl-3-carboxylate (CxT-AM), a nitroxiradical, as a spin probe for ESR measurement. 4-Carboxy-2,2,6,6-tetramethyl-piperidine-1-oxyl (CxT) was purchased from Aldrich Chemical (Milwaukee, WI). Briefly, CxT-AM was synthesized by esterification of CxT with acetoxymethylbromide by slight modification of the synthesis of acetoxymethyl-2,2,5,5-tetramethylpyrrolidine-1-oxyl-3-carboxylate, as described previously (36) . Acetoxymethylbromide was prepared by stirring paraformaldehyde (2.44 g) in acetylbromide (6.0 ml) for 30 min at 80°C. After the paraformaldehyde disappeared, the mixture was distilled at 130-138°C, and a yellow oil was obtained (4.54 g, yield 37%). The resulting acetoxymethylbromide (1.38 g) was added at 0°C to a mixture of CxT (1.0 g) and triethylamine (0.78 ml) in dimethylformamide (10 ml), and then stirred for 7 days at room temperature. After diluting with 40 ml of dichloromethane, washing once with water, and drying with manganese sulfate, the dichloromethane was evaporated. The residue was at first purified with silica gel column chromatography (Silicagel 60; Merck, Darmstadt, Germany), and then recrystallized from ether-hexane (bright red fine needle, yield 0.4 g [32%]). The purity was estimated with ESR, infrared spectroscopy, and fast atom bombardment mass spectrometry. Synthesized CxT-AM was used as a spin probe for ESR measurement. Measurement of ROS by ESR spectroscopy. The procedures for ESR with spin probes and nitroxide radicals in cultured cells were described previously (37) (38) (39) (40) . Briefly, the cells were removed from the dishes by treatment with 0.25% trypsin, centrifuged at 800g for 5 min, and suspended in the medium without serum at a concentration of 1 ϫ 10 7 cells/ml. The nitroxide radical CxT-AM was added to the cell suspension at the final concentration of 20 µmol/l, and the samples were mixed quickly but gently. Then, immediately, the samples were drawn into a gas-permeable Teflon tubes (Zeus Industries, Raritan, NJ) and inserted into a quartz ESR tube open at each end. Experiments were performed at 37°C. The typical time interval between addition of CxT-AM and the beginning of data collection was 2 min or less. ESR spectra were recorded with an ESR spectrometer (JES-RE-1X; JEOL) operating at X-band (9.45 GHz). The microwave power was 10 mW, the field modulation width was 0.2 mT, and the magnetic field range was swept at a scan rate of 5 mT/min. These procedures did not alter cell viability, as measured by exclusion of Trypan blue. As shown in Fig. 1 , CxT-AM was hydrolyzed inside the cells, retained in the cytoplasm, and then reduced to the corresponding hydroxylamine, leading to the loss of paramagnetism (36) . The ESR signal intensity decreased gradually after administration, and the signal decay curve of CxT-AM was obtained by semilogarithmically plotting the peak heights of the ESR signals. The curve was almost linear over the first 5 min of decay, allowing the initial velocity as the clearance constant (spin clearance rate) (Fig. 1) . The spin clearance rate represents the rate of radical generation in intact cells. Extraction and assay of DAG. For the experiments, cells were allowed to reach confluence in 35-mm dishes, and then the medium was changed to DMEM supplemented with various concentrations of palmitate and 1% serum. At the end of the desired exposure time, the experiment was terminated by the addition of ice-cold methanol. Samples were harvested and transferred to chloroform-resistant tubes. After addition of 2 ml chloroform and 1 ml H 2 O to the samples, total lipids were extracted according to the methods of Bligh and Dyer (41) . Total DAG was measured by an enzymatic assay kit using DAG kinase (Amersham, Arlington Heights, IL), as previously reported (35) . Briefly, the resulting 32 P-phosphatidic acid that was converted from DAG by DAG kinase in vitro was separated on silica gel G thin layer plates and developed in chambers using a solvent of chloroform-acetone-methanol-acetic acid-water (10:4:3:1). The spots of phosphatidic acid visualized by autoradiography were scraped from the plates into vials, and radioactivity was determined by liquid scintillation counting. PKC assay. PKC activity was measured by in situ PKC assay in digitonin-permeabilized cultured smooth muscle cells, as previously reported (42) . For the assay, the cells were cultured on six-well flat-bottomed microtiter plates. After confluence, the medium was changed to DMEM containing various concentrations of palmitate and 1% serum. At the end of the desired exposure time, the medium was aspirated and replaced with a buffered salt solution containing 137 mmol/l NaCl, 5.4 mmol/l KCl, 10 mmol/l MgCl 2 , 0.3 mmol/l sodium phosphate, 0.4 mmol/l potassium phosphate, 25 mmol/l ␣-glycerophosphate, 5.5 mmol/l D-glucose, 5 mmol/l EGTA, 1 mmol/l CaCl 2 , 100 µmol/l 32 P ATP (Amersham), 50 µg/ml digitonin, and 20 mmol/l HEPES (pH 7.2, 30°C). In addition, a 100 µmol/l PKC-specific octapeptide substrate (VRKRLRRL) was added to the buffer. The kinase reaction proceeded for 10 min at 30°C before termination by the addition of 10 µl of 25% (wt/vol) trichloroacetic acid. DIABETES, VOL. 49 
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Aliquots (45 µl) of the reaction mixture were spotted onto 2-cm phosphocellulose filter (Whatman P-81), and the filter was washed three times with 75 mmol/l phosphoric acid. The PKC-dependent phosphorylation of the peptide substrate bound to the filter was quantified by scintillation counting. Statistical analysis. Statistical analysis was performed by analysis of variance followed by Fisher's comparison test.
RESULTS
For these experiments, aortic smooth muscle cells and endothelial cells were allowed to reach confluence in 100-mm dishes, and then the medium was changed to DMEM supplemented with 1% serum and high glucose level (400 mg/dl) or normal glucose level (100 mg/dl). Exposure of cultured smooth muscle cells to high glucose level for 72 h induced a significant (P < 0.01) increase in the spin clearance rate compared with exposure to normal glucose level ( Fig. 2A) , suggesting a persistent stimulatory effect of high glucose level on free radical production. Treatment of the cells with phorbol myristic acid (PMA) (5 ϫ 10 -7 mol/l) (Sigma, St. Louis, MO) for 3 h also significantly (P < 0.01) increased the spin clearance rate ( Fig. 2A) , suggesting a stimulatory effect of PMA on free radical production. In cultured endothelial cells, exposure to high glucose level and treatment with PMA also induced a significant (P < 0.01, P < 0.01, respectively) increase in the spin clearance rate (Fig. 2B) . To evaluate the role of NAD(P)H oxidase, the effect of diphenylene iodonium, a NADPH oxidase inhibitor, on the spin clearance rate was examined. Treatment of smooth muscle cells with diphenylene iodonium (10 -5 mol/l) for 2 h completely restored the increased spin clearance rate induced by both high glucose level and PMA to the control value (Fig. 3A) . In contrast, treatment for 2 h with inhibitors of other flavoproteins, such as xanthine oxidase (oxypurinol, 100 µmol/l), nitric oxide synthase (l-N-monomethyl arginine, 10 µmol/l), and mitochondrial electron transport chain (rotenone, 100 µmol/l), did (Fig. 3B) . These results suggest that both high glucose level and PMA may stimulate ROS production through activation of NAD(P)H oxidase. To confirm the role of PKC in the stimulatory effect of high glucose level, the effect of PKC inhibitor was also examined. Treatment with GF109203X (5 ϫ 10 -7 mol/l) (Sigma) or calphostin C (5 ϫ 10 -7 M) (Sigma) for 2 h significantly (P < 0.05, P < 0.05, respectively) inhibited the increased spin clearance rate by high glucose level or PMA to the control value ( Fig. 4A and B) .
As for palmitate, we first examined the effect of palmitate on the DAG-PKC pathway in cultured smooth muscle cells. A stock solution of palmitate was prepared by dissolving it in 0.1 N NaOH solution in a bath of boiling water. Appropriate volumes of these stock solutions, freshly prepared before each experiment, were then added slowly and during continuous agitation to the test medium with 1% serum. Palmitate at a concentration of 200 µmol/l, which is a physiological concentration in plasma, increased DAG level in a timedependent manner (0-24 h), and the maximal DAG level lasted up to 72 h in cultured smooth muscle cells. As shown in Fig. 5 , exposure of the cells to palmitate (200 µmol/l) for 72 h significantly increased both DAG level and PKC activity (P < 0.01, P < 0.05, respectively). Next, exposure of both smooth muscle cells and endothelial cells to palmitate (200 µmol/l) for 72 h induced a significant increase in the spin clearance rate (P < 0.01, P < 0.01, respectively) (Fig. 6) . Again, diphenylene iodonium (10 -5 mol/l) completely restored the increased spin clearance rate induced by palmitate to the control value in cultured smooth muscle cells (Fig. 7A) . PKC inhibitors, such as GF109203X or calphostin C, also significantly (P < 0.05, P < 0.05, respectively) inhibited the increased spin clearance rate (Fig. 7A) . Similar results were obtained in cultured endothelial cells (Fig. 7B) . 5) . Recently, we also confirmed the increased oxidative stress in streptozotocin-induced diabetic rats using noninvasive in vivo ESR measurement (6) . It has been postulated that hyperglycemia may produce ROS through AGE formation (3, 4) and altered polyol pathway activity (5) . However, recent studies have revealed that vascular cells, such as smooth muscle cells and endothelial cells, can produce ROS through activation of NAD(P)H oxidase (7) (8) (9) (10) (11) (12) . In addition, Mohazzab et al. (7) and Rajagopalan et al. (9) have shown that this enzyme is the most important source of ROS in intact arteries rather than arachidonic acid-metabolizing enzymes, xanthine oxidase or mitochondrial sources. In the present study, we showed that chronic exposure of aortic smooth muscle cells and endothelial cells to a high glucose level induced a significant increase in free radical production, as evaluated by ESR spectroscopy. Furthermore, this increase in free radical production induced by high glucose was completely restored to the control value by diphenylene iodonium, a NAD(P)H oxidase inhibitor. Although diphenylene iodonium can inhibit several other flavoproteins, such as xanthine oxidase, nitric oxide synthase, and mitochondrial electron transport chain, the present results showed that specific inhibitors of these enzymes were ineffective for restoring the increase in free radical production induced by high glucose. These results suggest that high glucose level may stimulate ROS production through activation of NAD(P)H oxidase in aortic smooth muscle cells and endothelial cells. The NADPH oxidase system has been well characterized in phagocytic cells, where it consists of cytosolic components, p47 phox and p67 phox (43, 44) , a low molecular weight G-protein, Rac 1 or Rac 2 (45, 46) , and a membrane-associated cytochrome b558. In phagocytes, cytochrome b558 consists of a 22-kDa ␣-subunit (p22 phox ) and a glycosylated 91-kDa ␤-subunit (gp91 phox ) (47) . In a variety of nonphagocytic cells, including vascular smooth muscle cells and endothelial cells, these components of phagocyte-type oxidase (8, 11, 48) or Mox-1 (49), a variant form of gp91 phox , have been detected, confirming the role of NAD(P)H oxidase in ROS production in vascular cells. In phagocytic cells, it is well recognized that PKC can activate NADPH oxidase by phosphorylation-dependent activation of p47 phox (13) , p67 phox (14) , and/or Rac (15) . The present study shows that PMA, an activator of PKC, stimulated ROS production in both cultured aortic smooth muscle cells and endothelial cells. tured vascular cells was significantly inhibited by both GF109203X and calphostin C, PKC-specific inhibitors, suggesting the role of PKC. It is well established that high glucose activates PKC through an increase in de novo DAG synthesis in vascular cells (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . Taken together, the present results strongly suggest that high glucose level stimulated ROS production through PKC-dependent activation of NAD(P)H oxidase in cultured vascular cells. Although PKC inhibitor normalized the increased ROS production induced by high glucose level statistically completely, it should be stated that phosphatidic acid also can stimulate NADPH oxidase (50, 51) . Because phosphatidic acid is an intermediate of de novo DAG synthesis, its level should be increased by high glucose level. Increased phosphatidic acid level might in part contribute to the increased ROS production induced by high glucose level. In addition, this oxidase preferentially utilizes NADH rather than NADPH as a substrate in vascular cells (8) , which is in contrast to the phagocytic enzyme. High glucose level was reported to induce an increase in the ratio of cytosolic NADH:NAD + through an increased polyol pathway (5) . This might also be in favor of the high glucose-induced increase in ROS production through NAD(P)H oxidase in vascular cells.
Migration and proliferation of vascular smooth muscle cells are contributory events in vascular lesions associated with atherosclerosis and restenosis after vascular injury. ROS are reported to elicit specific growth and induce the expression of growth-related genes, including c-fos, c-myc, and c-jun (52) (53) (54) . Furthermore, this ROS production through NAD(P)H oxidase has been implicated in the pathogenesis of angiotensin II-induced hypertension and vascular smooth muscle hypertrophy (8, 10, 12) . In endothelial cells, cytokine-induced expression of vascular cell adhesion molecule-1 has been reported to involve ROS-mediated mobilization of nuclear factor-B and can be blocked by antioxidant (55) (56) . The expression of vascular cell adhesion molecule-1 promotes monocyte adhesion to endothelial cells and may be an important event in the development of atherosclerosis (57) . Because the ROS generated by vascular NAD(P)H oxidase appears to be released outside the cell as well as inside the cell (49), the ROS released outside the cell may contribute to impaired endothelium-dependent vascular relaxation by inactivation of nitric oxide (9) . Thus, taken together with these findings, the present results suggest that the increased ROS production through PKC-dependent activation of NAD(P)H oxidase in vascular cells induced by high glucose level may contribute to excessive acceleration of atherosclerosis in patients with diabetes.
Both diabetes and the insulin-resistant state are linked with atherosclerosis. One of the links between insulin resistance and atherosclerosis may be elevated plasma FFAs. This notion is supported by several reports showing that FFA may affect vascular functions. Raising plasma FFAs in minipigs with intralipid and heparin acutely elevates vascular resistance and raises blood pressure (31) . Raising FFAs systematically in healthy normotensive volunteers impairs the lower extremity vascular response to methacholine, an endotheliumdependent dilator (32) . The elevated FFAs in obese hypertensive subjects are extremely resistant to suppression by insulin and correlate with blood pressure (33, 34) . Previously, we showed that palmitate, which is a major saturated FFA in plasma, increased DAG level in cultured aortic endothelial cells (35) . Because excessive influx of palmitate into vascular cells could lead to an increase in acyl-CoA levels, the mechanism for the stimulatory effect of palmitate on DAG levels was supposed to be an increase in the de novo DAG synthesis by step-wise acylation. In the present study, we confirm that palmitate increased DAG level and PKC activity in cultured aortic smooth muscle cells. The detailed mechanism for palmitate-induced activation of the DAG-PKC pathway should be determined in future study. The present results showed that palmitate also stimulated ROS production in cultured aortic smooth muscle cells and endothelial cells. Again, this increased production of ROS was completely restored to control value by diphenylene iodonium and significantly inhibited by the PKC inhibitors GF109203X and calphostin C. These results suggest that palmitate as well as high glucose level may stimulate ROS production through PKC-dependent activation of NAD(P)H oxidase in cultured vascular cells. If increased DAG levels by palmitate may be due to the increased de novo synthesis, an increased phosphatidic acid level might in part contribute to the increased ROS production induced by palmitate. The increased ROS production induced by FFAs, such as palmitate, in vascular cells may lead to the altered vascular functions and may in part account for excessive acceleration of atherosclerosis in patients with insulin resistance syndrome.
In conclusion, the present study provides the first evidence that high glucose level and FFA (palmitate) stimulate ROS production through PKC-dependent activation of NAD(P)H oxidase in cultured aortic smooth muscle cells and endothelial cells. This may in part account for the excessive acceleration of atherosclerosis in patients with diabetes and patients with insulin resistance syndrome.
